These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28092607)
1. ProANP as a screening biomarker for hypertrophic cardiomyopathy in Maine coon cats. Parzeniecka-Jaworska M; Garncarz M; Kluciński W Pol J Vet Sci; 2016 Dec; 19(4):801-807. PubMed ID: 28092607 [TBL] [Abstract][Full Text] [Related]
2. Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy. Hsu A; Kittleson MD; Paling A J Vet Cardiol; 2009 May; 11 Suppl 1():S63-70. PubMed ID: 19395334 [TBL] [Abstract][Full Text] [Related]
3. Association of A31P and A74T polymorphisms in the myosin binding protein C3 gene and hypertrophic cardiomyopathy in Maine Coon and other breed cats. Wess G; Schinner C; Weber K; Küchenhoff H; Hartmann K J Vet Intern Med; 2010; 24(3):527-32. PubMed ID: 20412438 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of myocardial hypertrophy in a population of asymptomatic Swedish Maine coon cats. Gundler S; Tidholm A; Häggström J Acta Vet Scand; 2008 Jun; 50(1):22. PubMed ID: 18564408 [TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlation between the cardiac myosin binding protein C mutation A31P and hypertrophic cardiomyopathy in a cohort of Maine Coon cats: a longitudinal study. Granström S; Godiksen MT; Christiansen M; Pipper CB; Martinussen T; Møgelvang R; Søgaard P; Willesen JL; Koch J J Vet Cardiol; 2015 Dec; 17 Suppl 1():S268-81. PubMed ID: 26776585 [TBL] [Abstract][Full Text] [Related]
6. Precision medicine validation: identifying the Ontiveros ES; Ueda Y; Harris SP; Stern JA; J Feline Med Surg; 2019 Dec; 21(12):1086-1093. PubMed ID: 30558461 [TBL] [Abstract][Full Text] [Related]
7. NT-proBNP measurement fails to reliably identify subclinical hypertrophic cardiomyopathy in Maine Coon cats. Singh MK; Cocchiaro MF; Kittleson MD J Feline Med Surg; 2010 Dec; 12(12):942-7. PubMed ID: 21036088 [TBL] [Abstract][Full Text] [Related]
8. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study. Jung SW; Kittleson MD J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of the myosin-binding protein C mutation in Maine Coon cats. Fries R; Heaney AM; Meurs KM J Vet Intern Med; 2008; 22(4):893-6. PubMed ID: 18498321 [TBL] [Abstract][Full Text] [Related]
10. N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy. MacLean HN; Abbott JA; Ward DL; Huckle WR; Sisson DD; Pyle RL J Vet Intern Med; 2006; 20(2):284-9. PubMed ID: 16594584 [TBL] [Abstract][Full Text] [Related]
11. The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure. MacDonald KA; Kittleson MD; Larson RF; Kass P; Klose T; Wisner ER J Vet Intern Med; 2006; 20(5):1093-105. PubMed ID: 17063701 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of the MYBPC3-A31P mutation in a large European feline population and association with hypertrophic cardiomyopathy in the Maine Coon breed. Mary J; Chetboul V; Sampedrano CC; Abitbol M; Gouni V; Trehiou-Sechi E; Tissier R; Queney G; Pouchelon JL; Thomas A J Vet Cardiol; 2010 Dec; 12(3):155-61. PubMed ID: 21051304 [TBL] [Abstract][Full Text] [Related]
13. Prospective echocardiographic and tissue Doppler imaging screening of a population of Maine Coon cats tested for the A31P mutation in the myosin-binding protein C gene: a specific analysis of the heterozygous status. Carlos Sampedrano C; Chetboul V; Mary J; Tissier R; Abitbol M; Serres F; Gouni V; Thomas A; Pouchelon JL J Vet Intern Med; 2009; 23(1):91-9. PubMed ID: 19175727 [TBL] [Abstract][Full Text] [Related]
14. Re: Association of A31P and A74T polymorphisms in the myosin binding protein C3 gene and hypertrophic cardiomyopathy in Maine Coon and other breed cats. Kittleson MD; Meurs K; Munro M J Vet Intern Med; 2010; 24(6):1242-3; author reply 1244. PubMed ID: 21054533 [No Abstract] [Full Text] [Related]
15. Effect of spironolactone on diastolic function and left ventricular mass in Maine Coon cats with familial hypertrophic cardiomyopathy. MacDonald KA; Kittleson MD; Kass PH; White SD J Vet Intern Med; 2008; 22(2):335-41. PubMed ID: 18346145 [TBL] [Abstract][Full Text] [Related]
16. Assessment of regional left ventricular systolic function by strain imaging echocardiography in phenotypically normal and abnormal Maine coon cats tested for the A31P mutation in the MYBPC3 gene. Pellegrino A; Daniel AG; Pereira GG; Itikawa PH; Larsson MH Can J Vet Res; 2017 Apr; 81(2):137-146. PubMed ID: 28408782 [TBL] [Abstract][Full Text] [Related]
17. Circulating concentrations of a marker of type I collagen metabolism are associated with hypertrophic cardiomyopathy mutation status in ragdoll cats. Borgeat K; Dudhia J; Luis Fuentes V; Connolly DJ J Small Anim Pract; 2015 Jun; 56(6):360-5. PubMed ID: 25622655 [TBL] [Abstract][Full Text] [Related]
18. Measurement of N-terminal proatrial natriuretic peptide in plasma of cats with and without cardiomyopathy. Zimmering TM; Meneses F; Nolte IJ; Simon D Am J Vet Res; 2009 Feb; 70(2):216-22. PubMed ID: 19231954 [TBL] [Abstract][Full Text] [Related]
19. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats. Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959 [TBL] [Abstract][Full Text] [Related]
20. Body size and metabolic differences in Maine Coon cats with and without hypertrophic cardiomyopathy. Freeman LM; Rush JE; Meurs KM; Bulmer BJ; Cunningham SM J Feline Med Surg; 2013 Feb; 15(2):74-80. PubMed ID: 23001953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]